A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Capsaicin (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms VICTORY-1
- Sponsors Centrexion Therapeutics
- 21 Feb 2018 According to a Centrexion Therapeutics media release, the first patient has been dosed in this trial.
- 08 Feb 2018 Status changed from planning to recruiting.
- 16 Jan 2018 According to a Centrexion Therapeutics media release, this trial is expected to initiated in the first quarter of 2018.